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Concerns about problems of the breast are often noted in 
adolescents and their parents. This review discusses issues and 
disorders of the breast in children and adolescents, starting with 
basic principles of embryology and adolescent breast development. 
Concepts that are covered include congenital breast disorders, 
abnormal timing of breast development, breast asymmetry, 
underdeveloped breasts, breast atrophy, tuberous breasts, mammary 
hyperplasia, fibroadenoma, giant fibroadenoma, cystosarcoma 
phyllodes, intraductal breast papilloma, adenocarcinoma, mastitis, 
traumatic breast disorders, benign breast disease, fibrocystic 
change, mastalgia, gynocomastia, and galactorrhea. A number of 
figures are provided illustrating breast pathology. Clinicians caring 
for children and adolescents are encouraged to provide careful 
assessments of this important organ system.   
INTRODUCTION 
The breast is a modified sweat gland enveloped by superficial thoracic 
fascial layers and suspended from the chest wall by Cooper's ligaments 
(fibrous septae), extending from the pectoralis fascia to the dermis (1,2). 
Breast concerns and disorders are an often ignored part of health care, 
sometimes neglected by the clinician, and typically worried about by the 
child or adolescent. Parents may be anxious about perceived breast 
problems in their child while the adolescent may present with 
unexpressed concerns about this body system. Body image and self 
esteem issues in girls may be strongly associated with breast appearance 
and breast development during the adolescent years. Breasts (mammary 
glands) are estrogen-dependent organs that indicate sex development, 
functional activity of ovary, and development of reproductive function. 
Diagnosis and treatment of breast disorders are important tasks for 
clinicians who care for children and adolescents (3-5). Examination of 
the breasts may occur as part of a comprehensive physical examination 
or because anxiety is raised about a possible problem. This review 
presents common concerns and problems of the breast that may arise in 
children and adolescents (6-8). 
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EMBRYOLOGY
During the 4th to the 6th fetal week, epidermal cells migrate into 
underlying mesenchyme, resulting in the development of primitive 
mammary ridges or milk lines (9). Ectodermal thickening occurs from 
the axilla to the groin. Atrophy of the upper and lower parts of these 
ridges usually occurs around the 10th fetal week, allowing the middle or 
pectoral ridges to eventually become normal breast tissue. Lactiferous 
duct  and mammary glands later develop from these ridges, while the 
surrounding mesenchyme becomes fibrous and adipose tissue within the 
breast. Solid cords, usually 15 to 20 in number, result from secondary 
buds in the breast tissue; these cords later become milk ducts and lobes 
of the breasts. The areola develops in the 5th month of fetal life and the 
nipple is normally seen shortly after birth.  
NORMAL ADOLESCENT BREAST DEVELOPMENT
Childhood breasts are composed of ducts that are lined with epithelium 
and surrounded by connective tissue; the child's breast tissue usually is 
dormant until puberty ensues (9). As puberty develops, female breasts 
change due to the· increase of the hormones estrogen, progesterone, and 
eventually, prolactin. However, during premature (isolated) thelarche/ 
premature breast development, the level of estrogen is not increased. 
Some researchers believe that testosterone could have specific influence 
for breast development, but this opinion is still controversial (10). For 
example, absence of suppressive effects of testosterone for breast 
development in girls with a low estrogen level who are not sensitive to 
androgen, could lead to normal size breasts, as in the case of androgen 
insensitivity syndrome (testicular feminization syndrome). Perhaps 
breasts develop under increasing estradiol secretion by testicles and 
peripheral aromatization of testosterone (10). Other hormones needed for 
normal breast growth include thyroxine, insulin, growth hormone, and 
adrenal corticosteroids. Deficiency in one or more of these hormones can 
result in defects of the breast organ. 
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At first in early puberty, there is an increase in adipose tissue along 
with initial growth of ductal and stromal tissue because of the effects of 
estrogen; increase in pigmentation and size of the areola are also due to 
estrogen effects. The increase in progesterone leads to alveolar budding, 
lobular growth, and secretory growth of lobules and alveoli; however, 
true alveoli only appear during pregnancy (11). 
The growth of female breasts is divided into five stages, classically 
called Tanner Stages or Sexually Maturity Stages (SMR) (see figure 1) 
(12). The SMR stages of Tanner from 1962 were based on classic work of 
Reynolds and Wines in 1948 that was itself based on earlier work of 
Stratz in 1909 (1,2). There is no breast development in stage 1, the classic 
breast bud is stage 2, the small breast appearance is stage 3, the double-
contoured appearance is stage 4 (due to the areola/nipple complex 
forming one mound on top of the breast tissue mound), and the single 
contour appearance with the nipple forming a little round edge on the 
top, is stage 5 (fully mature breast). Some adolescent females may not 
develop a stage 5 breast and may have the stage 4 appearance throughout 
adulthood. Persistence of stage 4 in adult life does not pose problems in 
general, though special advice and preparation is needed for lactation. 
A number of clinical correlations are noted with the SMR stages (see 
table 1). Alveolar cells change into secretory cells, with full maturation 
developing later with the production of prolactin inducing alveoli that are 
lined with mild secreting cells. Edema fluid can increase in size by 50% 
during the luteal phase of the cycle and these females could eventually 
develop symptoms of premenstrual tension (PMT)/premenstrual 
syndrome (PMS) that include breast tenderness and swelling. 
The mature breast can increase two to three times in size due to 
pregnancy, from the second month of pregnancy, under the influence of 
estrogen and progesterone produced by the placenta, and also lactation. 
The breasts start to enlarge due to increased fat deposition and glandular 
proliferation with potential doubling of the breast blood flow. Breast 
anatomy is shown in figures 2-4 (13,14). There are 15-20 lobes, 
consisting of 20-40 lobules which include 10-100 alveoli. The areola 
contains numerous Montgomery (sebaceous) glands (11). 
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Table l. Clinical correlations with Tanner Stages* 
Clinical features 
Hematocrit rise in males 
Alkaline phosphatase peak 
Rise in serum uric acid levels (male) 
Mild regression of virginal hypertrophy 
(of breast) 
Different counseling about concern for 
breast size 
Appearance o f  menarche Appearance 
of"normal" gynecomastia 
(males) 
Use of contraceptives 
Use of diaphragm 
Neisseria gonorrhoeae inf'ection 
Vaginitis 
Cervictis 
Timing of breast reduction or rhinoplasty 
Short male with growth potential 
Short male with limited growth potential 
Appearance of acne vulgaris 
Decreased incidence of serous otitis 
media 
Development of orthopedic disorders 
(Osgood-Schlatter disease, slipped capital 
femoral epiphysis, significant worsening 
of scoliosis) 
Strong suspicion of organic disease 
Tanner stage 
II-V 
II or III 
Regression of stages or 
unusual delay in stage 
progression 
II in female, III in male 
II-IV
V
II or V
Late III or IV 
IV
IV or V
I
II+
V
II
IV
II or III
Post-II or III
II-III (II-IV for scoliosis)
*Used with permission from: Greyadanus DE, Parks D, Farrell E. Disorders of the
 breasts in children and adolescents. Pediatr Clin North Am 1989;36:601-38
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Figure 1. Tanner Stages or Sexually Maturity Rating Stages (SMR). 
Front View of Breast 
Figure 2.  Breast  Anatomy. 
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Figure 3. Breast Anatomy. 
Skin 
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Figure 4. Breast Anatomy. 
BREAST EXAMINATION 
Self-examination 
Many clinicians would not recommend routine self-breast examinations 
in adolescent females (except in those with a family or personal history 
of breast cancer), since breast malignancy is rare in this age group and it 
may produce increased psychological distress searching for such a rare 
condition; also, adolescents often do not exam themselves routinely for 
various reasons including  limited  knowledge  of  their  bodies  and  busy  life 
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activities that block their attention for such a recommendation. 
Arguments for encouraging youth to start breast exams is that it prepares 
them for such self-examinations as adults and that it is an effective way 
to find breast pathology. 
Clinicians' examinations 
A number of methods for breast examination have been described and 
can be applied depending on the purpose of the examination (4,14). The 
male clinician may perform a limited exam, because of his own anxiety, 
concern over the patient's reaction to a breast exam, or out of a belief 
that no pathology is present in an adolescent. The male clinician may feel 
more comfortable with a chaperone in the room during the breast 
examination, as typically occurring during a pelvic examination (4). It is 
important to assess if the patient has any concerns about her breasts-
such as being too small, too large, asymmetrical, or other. The exam can be 
used to provide often needed education about this important part of her 
body and its implications for current and future sexuality. 
The adolescent should be taught that there is considerable amount of 
normal variation of breast size, shape, and consistency. Nipple size may 
also be quite varied. Swelling or enlargement may be noted along the 
outer lateral breast tissue curve extending into the axilla; this "axillary 
tail of Spence" is normal and can enlarge during puberty and pregnancy. 
There is also a normal variation in areolar hair, especially in some ethnic 
groups; however, this can be the first symptom of hyperandrogenemia 
and hirsutism (15,16). Plucking these hairs can lead to ingrown hairs and 
infection. If these hairs are bothersome, they can be cut short. A normal 
finding is a variable amount of areolar gland discharge and this should 
not be confused with galactorrhea. Also, the areola contains Montgomery 
tubercles that may temporarily secrete a whitish discharge under the 
stimulation of puberty, pregnancy, or lactation; it is not a disorder, is 
transient, and the only treatment is simple reassurance of  its normalcy. 
A number of tests have been used to delineate breast pathology. 
Masses may be evaluated with fine-needle aspiration (FNA), core-needle 
biopsy (CNB), or excisional biopsy (4,17, 18).  A mammogram is usually 
not very helpful in adolescent females, because of the breast denseness 
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(i.e., increased fibroglandular to fatty tissue ratio) and also if the breasts 
arc small (19). Ultrasonography is more effective at delineating masses 
within the immature breast (4,18,20). Color Doppler ultrasonography 
may increase the specificity of the diagnosis; cysts are avascular, 
fibroadenomas are hypovascular, and abscesses show increased 
peripheral flow (21). Computerized tomography (CT) may be necessary 
to locate a lesion in the breast tissue versus chest wall or other structures. 
The combination of palpation, imaging, and biopsy (FNA or CNB) is 
called the "triple test'' of breast lesion evaluation (17,22).  
CONGENITAL ANOMALIES 
Nipple anomalies 
A number of breast congenital anomalies can be seen, as noted in table 2. 
Polythelia or extra nipples, is described in 1% to 2% of the general 
population, and may be associated with ocher anomalies, such as 
genitourinary or cardiovascular defects (see figures 5,6) (9,14). These 
accessory nipples can be located anywhere along the milk lines,   from the 
axilla to the groin (see figure 7); other sites have been noted as well, such 
as over the back or buttock (4). The nipple and areola of the accessory 
tissue is usually smaller than a normal nipple and may be mistaken for a 
mole, melanoma, or hemangioma (see figure 8). Excision of the extra 
nipple (s) is the typical management if the patient requests a cosmetic 
removal. 
Table 2. Congenital anomalies of the breast 
Polythelia 
Athielia 
lnverted nipples 
Bifid nipple 
Depressed nipple 
Polymastia  
Symmastia 
Amastia 
Poland syndrome 
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. ". . . . ' ' 
Figure 5. Congenital anomalies: two nipples (right breast) in a 14 year old girl. 
Mole is seen at the medial aspect of right breast 
' 
Figure 6. Accessory nipple or polythelia (arrow). 
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Figure 7. Embryonic milk tines . 
Figure 8. Hemangioma in the left breast in a 16 year old girl. 
Breast Disorders in Children and Adolescents 257 
An inverted nipple is one that does not project beyond the breast 
surface and is noted at birth; it is typically bilateral and usually reverts to 
normal in a few weeks. If persistent into the adolescent years, cosmetic 
and lactation concerns often arise. The infraareolar breast tissue can be 
compressed and may lead to nipple protrusion. Infection can develop in 
an inverted nipple unless hygiene is excellent at all times and can lead to 
chronic areolar abscesses with swelling, erythema, pain, and discharge of the 
involved nipple (s). Management includes local beat application, 
antibiotics, and surgery co divide the breast ducts and raise the nipple; 
however, breast feeding potential is then typically compromised. Acute 
onset of nipple inversion in adolescence or adulthood suggests such 
problems as duct ectasia or malignancy that commonly presents as 
unilateral nipple inversion. 
Other nipple anomalies include a bifid nipple (see figure 9) and a 
depressed nipple; the latter involves lactiferous ducts that directly open into 
a depressed areolar center and if severe, breast feeding is prevented. 
Management is with surgical correction as with the inverted nipple. The 
absence of a nipple,  athelia, is a very rare condition and may also be seen 
as a unilateral, bilateral, and/or familial condition; it may occur with 
exposure to exogenous androgen taken during pregnancy.  
Figure. 9. Bifid nipple. A rare breast anomaly that is a partial duplication of the 
nipple. 
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Polymastia/Amastia 
Polymastia or supen1umerary breasts is noted less commonly than 
polythelia and like extra nipples (see figures 5,6), can be unilateral, 
bilateral, and/or familial. An extra breast (polymastia) or extra nipple 
(polythelia) occurs in approximately 1% of the population and may be an 
inherited condition (23). Supernumerary nipples are slightly more 
common in males than in females. The extrabreast tissue can be seen 
anywhere along the milk lines, but they are typically found below a 
normal breast, on the chest or upper abdomen. Various combinations of 
nipple, areola and glandular breast tissue can be seen, leading to 
confusion with other conditions, including hidradenitis suppurativa. The 
extra tissue may become readily apparent with puberty, pregnancy, 
and/or lactation. This accessory tissue is usually removed for cosmetic 
and/or diagnostic reasons, but other indications include an axillary 
location and the presence of lactation. There are rare case reports of a 
malignancy developing in supernumerary breast tissue (24). Another rare 
congenital anomaly of the breast is symmastia, with breast tissue 
webbing or confluence in the midline. 
The absence of a breast (amastia) is rare and occurs because of 
complete mammary ridge involution, incluiling the pectoral ridge on the 
affected side. Amastia, like athelia, can be associated with chest wall 
anomalies as pectus excavatum or the Poland syndrome. The Poland 
syndrome (see figures I0,11) describes a condition with various 
combinations of anomalies, such as amastia, pectoralis muscle aplasia,  
rib defomuties, and upper limb defects (such as radial nerve aplasia and 
finger webbing) (1,2,4,9,14,25). Management includes surgical 
correction of the chest wall deformities. Amastia can be acquired because 
of damage from a breast bud biopsy, irradiation to the breast area, or 
other injury to breast tissue. An abnormal breast appearance can also be 
seen with pectus excavatum (see figure 12). 
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Figure 10. Poland Syndrome. 
Figure 11. Poland Syndrome (same patient as figure 10, lateral view). 
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Figure 12. Pectus Excavatum. A classic chest wall deformity that can affect the breast 
appearance. Reconstructivc surgery may improve the cosmetic appearance. 
TIMING OF BREAST DEVELOPMENT 
Thelarche (onset of breast development) begins at an average age of 10 
to 10 1/2 years of age with a normal variation of  6-8 years at the earliest to 
13 years at the latest, and it is the first sign of puberty in females in most 
cases (26-28). The exact timing of bow early breast development may 
arise before identifying it as premature remains debated by various 
experts. Some research suggests that thelarche may normally begin as 
early as age 6 years in African-Amelican children and 7 years in 
Caucasian children; approximately 48% of African-American females 
have thelarche between 8 and 9 years of age versus 1.5% of Caucasian 
females (29). Thus, the definition of precocious puberty and delayed 
puberty may vary from expert to expert. Once breast development 
begins, it usually takes 2 to 3 years for full breast development, and 
about two to three years (1 \4 -4 years) for menarche (onset of menstrual 
periods) (26,28). Some females remain at SMR 3 until pregnancy and 
they can be reassured of the normalcy of these breasts in a world often 
obsessed with "full" breasts.  
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The average age of menarche dropped in the United States from the 
1800s to the mid-1990s for reasons usually linked to improved nutrition 
and health as well as increased weight (26). There is no clear evidence 
that age of menarche continued to decline from the mid-1900s to the 
present and it appears to have stabilized at age 13 in Northern Europe. In 
less developed countries and those with warm climates, it appears to be 
still dropping (26). Earlier puberty may lead to earlier sexual activity 
with resultant complications of high risk behaviors, such as pregnancy, 
date violence, school failure, and others.  
Premature thelarche (see figure 13) is defined by the isolated 
appearance of breasts in the female child under age 6 to 8 years of age 
without other evidence of puberty (such as pubarche or menarche) (4,30). 
It has a prevalence of 2% and typically, is noted between ages 1 and 3 
years with normal laboratory studies (see table 3); sometimes, serum 
estradiol may be slightly increased. Table 4 lists potential causes of 
premature thelarche. A careful history is important to identify potential 
sources of exogenous estrogen exposure. Further evaluation reveals no 
estrogen effect on the vagina (i.e., vaginal cytology change), no further 
progression of breast tissue, and no other evidence of puberty (such as 
development of pubic hair, thickening of the vaginal mucosa, or 
accelerated bone growth). If no other signs of puberty are present, 
reassure the patient and family that· this is a benign finding. Examine the 
child every 6-12 months; if  other signs of puberty are evident, precocious 
puberty should be entertained as a diagnosis, In premature thelarche, the 
breast budding may persist until later puberty; if  there is breast 
development beyond SMR 2, it typical]y regresses until later, usually 
normal puberty occurs. 
Table 3. Potential  laboratory  studies  to evaluate  premature  thelarche 
Gonadotropins (LH, F'SH) 
Estradiol 
Vaginal cytology 
17-ketosleroids (urinary)  
DHEA 
Bone age 
Ultrasound (uterus and ovaries) 
Head CT/MRI (evaluate for pituitary/hypothalamic neoplasia) 
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Figure 13. Premature Thelarche in a 4  year old girl. 
Table 4. Causes of premature thelarche  
Genetics 
Increased estrogen sensitivity 
Increased estrogen (from the adrenal gland, dietary ingestion) 
Oral contraceptive exposure 
Transient secretion of estrogen from ovarian follicular cysts 
Application of estrogen cream to the nipples 
Transient activation (partial) of pubertal axis with increased FSH 
Primary hypothyroidism (with elevated TSH and prolactin) 
Sometimes premature thelarche represents an incomplete and benign 
form of precocious puberty, requiring periodic observation and 
reassurance. Early onset of puberty is more common in girls than in boys 
and is predominantly mediated by premature activation of the 
hypothalamic-pituitary-gonadal  axis  (30).    Central  (true)  precocious 
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puberty may be caused by hypothalamic hamartomas, trauma, 
hydrocephalus, and central nervous system lesions; however, it is most 
commonly idiopathic. Treatment depends on the underlying etiology. 
Gonadotropin-releasing hormone (GnRH) analogues are used to 
postpone puberty until an appropriate age and it could be helpful to 
optimize adult height potential (31). 
Peripheral precocious puberty (pseudo-precocious puberty) is due to 
sex steroid secretion independent of gonadotropin release, and it is much 
rarer than true precocious puberty; its causes include an estrogen- 
secreting tumor and the McCune-Albright syndrome. When suspecting 
precocious puberty, tests to obtain include luteinizing hormone (LH), 
follicle-stinmlating hormone (FSH), thyroid-stimulating hormone (TSH), 
thyroxine (T4), testosterone, and estradiol. If premature breast 
development arises along with other secondary sex characteristics, the 
diagnosis becomes precocious puberty and a careful evaluation is 
necessary for underlying organic causes (see table 5). Management is 
dependent on the underlying etiology. When hirsutism or virilization 
occurs with precocious puberty, adrenal tumors or late-onset adrenal 
hyperplasia must be excluded.  
Table 5. Causes of precocious puberty (partial list) 
Idiopathic (80-90% in females and 40% in males) 
Ovarian neoplasm in females or testicular tumor in males (10% vs. 15%
respectively)  
McCune-Albright syndrome (5% of females and 1% of males) 
CNS pathology (as neoplasm) (5-10% in females and 25%+ in males) 
Adrenal neoplasm/hyperplasia (1% in females and 25% in males) 
Hypothyroidism (rare) 
BREAST ASYMMETRY  
It is common for young adolescent females to have breast 
asymmetry; in some youth, one breast bud appears before the other starts 
while in some youth, asymmetry emerges after bilateral thelarche 
develops (4,9). Familial or genetic factors influence the timing of 
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puberty, the appearance of thelarche, and the rate of breast growth on 
both sides. Adequate symmetry eventually develops in most females by 
late adolescence. though approximately 25% of adult females have 
visible asymD1etry (see figure 14). Padding the smaller side may help 
while waiting to see if acceptable catch-up growth will take place as 
adolescence continues. Youth should be advised to avoid worthless "bust 
developers or pumps" that are sometimes adve1tised, though exercise can 
develop improved pectoralis muscle tone, partially improving the breast 
appearance. Application of estrogen cream is not recommended by most 
clinicians since the Jess developed breast may Jack estrogen receptors. 
Pseudoasymmetry may be present because scoliosis or a rib cage defect 
gives the illusion of unequal breast size. 
Also, a breast may not grow properly because of prepube1ial injury, 
trauma, or surgery that includes improper biopsy of a lesion that is 
actually a breast bud (1). In very young and preadolescent children, a 
biopsy should be considered with extreme caution because the 
developing breast bud may be irreparably harmed, even with a needle 
aspirate. Thoracostomy tube insertion, anterolateral thoracostomy, 
infection, and burns may also lead to breast damage. Burns usually lead to 
scarring with normal underlying breast tissue; the skin contractures 
should be released by early adolescence to allow normal breast 
development.  
Transient or permanent breast asymmetry can lead to considerable 
embarrassment and psychological distress. There may be a positive 
family history for delayed puberty. The small breast may represent 
partial end-organ failure or the larger breast may be due to a breast mass 
(see figure 15), as discussed later in this article. Surgery is the typical 
method of management for significant breast asymmetry when the 
patient is mature enough to understand the surgical options as well as 
risks, and provide legal consent. Surgery should be decided on by the 
youth in late adolescence or early adulthood so the patient is cognitively 
mature enough to make such a decision and also to allow for full 
development of both breasts that includes full catch-up growth of the 
smaller breast. 
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Figure 14. Breast Asymmetry. Of particular interest is the difference in size of the 
nipple - areolar complex and the overt difference in their location. 
Reconstructive surgery includes a combination of augmenting the. smaller breast       
or reducing the larger breast. 
One breast may be enlarged and/or the other reduced, depending on 
the precise situation. Augmentation mammoplasty has been a 
controversial procedure and the youth should clearly understand the 
potential benefits and risks associated with the procedure being offered. 
Surgical complications may include severe scarring, confusion with 
cancer later in life, and lactation dysfunction; also, innervation of the 
nipple is from the fourth intercostal nerve and surgical damage to this 
nerve may lead to loss of erotic sensation [32]. Sometimes it is not the 
breast volume that is of concern, but the breast shape that requires a 
breast lift or mastopexy. 
UNDERDEVELOPED BREAS'J'S 
Another common concern of some adolescent females is that of small 
breasts (micromastia; hypoplasia) (1,2,9). It may be found in someone 
simply in early puberty or in someone in later puberty with an  otherwise 
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normal examination and normal estrogenization (i.e., normal pubic hair, 
vagina, uterus, and female appearance), along with a normal menstrual 
history. Reassurance of normalcy is important, though breast 
enlargement surgery (augmentation mammoplasty) may be chosen at 
some point by this patient (32).  
Figure 15. Breast asymmetry due to a right breast lipoma. 
However, an evaluation may reveal variable degrees of bilateral 
hypoplasia or hypomastia plus ovarian dysfunction (see table 6) with 
failure of secondary sex characteristics and typically primary 
amenorrhea. The nipple..  are then abnormal as well--less pigmented, less 
protuberant, and smaller. A complete genetic and endocrine work-up is 
then recommended. Appropriate management of the underlying disorder 
is important, as hormonal management of Turner syndrome, for example. 
Table 6. Causes of bilateral breast hypoplasia and ovarian 
dysfunction/hypofunction 
Gonadal dysgenesis (Turner syndrome)  
Adrenal hyperplasia (as congenital adrenal hyperplasia) 
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Pituitary hypogonadism 
Preadolescent hypothyroidism 
Androgen-producing tumor 
Radiation effects 
Bilateral ovariectomy  
Malnutrition 
Deficiency of body weight (BMI<18.5) 
Some chronic illnesses 
Delay of sexual development 
Amenorrhea 
TUBEROUS BREASTS 
An unusual breast deformity has been described by Rees and Aston as 
tuberous breasts (tuberous breast anomaly) because the breasts have the 
appearance of a tuberous root plant (see figures 16,17) (4,33). There is 
limitation in the breast base ho1izontally and vertically in which the breast 
projects forward without normal fullness, but with an enlarged, 
overdeveloped nipple areola complex. Two types are described, Type 1 
and 2. Type 1 is the usually tuberous breast presentation with a small 
concentric breast base and a large nipple areola complex that represents 
herniation of breast tissue into the areola. The less common type, Type 2, 
presents with a breast that is more deficient in its vertical than horizontal 
dimension and has a small breast base. Management of type 1 is with 
augmentation of these hypoplastic breasts and reduction of the herniated 
breast tissue from the nipple areolar complex. Type 2 is treated with 
augmentation of these hypoplastic breasts. Mild cases may not require 
plastic surgery. 
BREAST ATROPHY 
Breast atrophy may develop after thelarcbe from various causes (see 
table 7) leading to breasts that become wrinkledd, flattened, ptotic, and 
senile in appearance (1,2,4).  Both the adipose and glandular tissues can 
268              Donald E. Greydanus, Hatim A. Omar, Lyubov Matytsina et al. 
be severely reduced. Restoration of the previous normal breast tissue is 
unlikely; however, some improvement may occur primarily with 
correction of the underlying problems and the use of oral contraceptives - 
if appropriate for those with an eating disorder (see figure 18) or other 
chronic illness. For example, scleroderma can cause variable amount of 
breast tissue atrophy.   
Table 7. Causes of breast atrophy 
Weight loss from severe dieting (especially a protein-poor diet) 
Anorexia nervosa 
Premature ovarian failure  
Scleroderma 
Other chronic illnesses causing significant weight loss 
Figure 16. Tuberous Breast Anomaly (Type I). 
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Figure 17. Tuberous Breast Anomaly (Type I). A closer view of Figure 16. 
Figure 18. Hypoplosia of breasts in a patient with Anorexia Nervosa, 17 years 
old.  
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MAMMARY HYPERPLASIA  
The condition in which breasts enlarge in the newborn period is called 
neonatal breast hypertrophy and development of large breasts during 
puberty has many terms, including mammary hyperplasia or idiopathic 
breast hypertrophy. Neonatal breast hypertrophy can be noted in as many 
as 70% of newborns (females and males) and is usually attributed to 
maternal estrogen effects ancVor an abnormal ratio of estrogen to 
androgen. Enlarged breasts are usually less marked in premature infants, 
presumably since immaturity does not allow as much breast reaction as 
noted in more mature newborns. The normal post-delivery withdrawal of 
maternal estrogen can lead to increased prolactin levels and the enlarged 
breasts in the newborn may produce a clear or cloudy (milk-like) nipple 
discharge ("witch's milk"). Freq1ent breast stimulation may lead to 
hyperplasia, nipple discharge, and mastitis. The hyperplasia usually 
resolves in a few days to few weeks,  though there are case reports of 
breast hype1trophy lasting up to 10 months in males and 2 years in 
females.   Breast carcinoma in infants with breast hypertrophy is 
extremely rare. 
Juvenile (virginal) breast hypertrophy 
In this situation, there is explosive breast growth often shortly after 
thelarche that is unilateral or bilateral and often familial (see figures 
19,20) (4,34). Extreme growth can rarely be seen and is called 
macromastia  or  gigantomastia, as noted by one case report in a 4'10", 
106 pound, 12-year-old whose left breast weighed 3,800 grams and right 
breast weighed 4,200 grams (1). The etiology is usually attributed to 
heightened response or sensitivity of breast tissue to pubertal hormones 
and endogenous hormone production from breast cells. Exposure to 
estrogen has been noted in some cases, as breast hypertrophy developing 
while on oral contraceptives. It also occurs during pregnancy. Juvenile 
hypertrophy appears to be more common in African-American females 
than Caucasian females. Potential sequelae are many, as listed in table 8 
(1,2,9). The differential diagnosis of unilateral hypertrophy includes a 
breast tumor, typically a giant fibroadenoma. 
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Table 8. Potential complications of breast hypertrophy 
Extreme embarrassment (for patient and family) 
Unwanted attention from males 
Secondary psychological difficulties 
Severe neck or back pai11 
Poor (kyphotic) posture 
Headaches (due to neck strain) 
Dermatitis and ulceration 
Breast tissue necrosis 
Stretching and flatrening of the areolae 
Difficulty with various physical activities, including sports 
Problems with finding proper fitting clothes 
Brachial plexus-induced paresthesias 
Massive enlargement: thoracic compression 
-Respiratory distress 
-Spinal curvature  
Figure 19. Bilateral Mammary Hyperplasia in a 14 year old girl. Also has 
polythelia on the right breast  
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Figure 20. Idiopathic breast hypertrophy in an adolescent.   
Management must be individualized and ranges from reassurance 
that the breast tissue is normal (with firm bra support), to surgery in 
order to reduce the breast size (9,35). There may be some regression of 
the hyperplasia later in adolescence, though this is typically mild if at all. 
Research has noted that medication (such as danazol, 
medroxyprogesterone, or dydrogesterone) used in adult females is not 
effective in management of mammary hyperplasia in adolescents and 
has a number of adverse effects, depending on which medication is used. 
It is recommended that surgery, if chosen by the patient, be done at a 
time when final breast enlargement bas occurred or the breasts are 
mature and the patient is mature enough to decide if as well as when this 
surgery should be accomplished (32). Surgery done earlier because of 
severe problems (se table 8) may be complicated by later recurrent 
hypertrophy as the breasts continue to grow. The surgery is reduction 
mammoplasty for unilateral or bilateral hyperplasia and the precise 
technique depends on the training of the surgeon. Post-operative 
complications include breast hematoma, infection, wound drainage, and 
fat necrosis. Other surgical sequelae include breast scarring (can be 
severe), loss of nipple sensation (5-25%), and lactation dysfunction. A  
link between cosmetic breast augmentation and suicide in adult women 
has been identified (36). 
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FIBROADENOMA 
Fibroadenoma is the most common breast tumor in adolescent females, 
noted in 70% to 95% of breast biopsies in this age group; it is the most 
common cause of a solid breast mass in females from puberty to age 30 
(1,2,4,9,14,22,37-40). In Stone's classic series of 165 youth between 
ages 11 and 20 years, 72% had a fibroadenoma in contrast to 12% with 
hyperplasia, 7% with an abscess, 6% with breast cystic disease, and 3% 
with intraductal papilloma (41). In Hein's review of 95 adolescents, 75% 
with biopsies had a fibroadenoma, in c:ontrast to 12% with an abscess, 
10% with cystic disease, 2% with a lipoma, and 2% with cystosarcoma 
phyllodes ( 42). Table 9 provides a list of breast mass pathology. 
A fibroadenoma typically presents as a rubbery, non-tender, 
encapsulated mass slowing increasing in size over weeks to months (see 
figure 21). Sometimes it is seen as an irregular or oval lump with a 
consistency that can vary from elastic to hard versus the typical rubbery 
type; nipple discharge is not noted. The lesion can be seen anywhere in 
breast tissue, though the upper, outer quadrants are the most common. It 
usually is 3 cm to 4 cm when found, but can continue to enlarge to 10 or 
15 cm if not removed in time. Large lesions can induce a malignancy-
like state with peau d' orange skin having erythema and enlarged veins 
overlying the tumor. Bilateral or multiple tumors, often called 
fibroadenomatis, are noted in 10% to 25% of cases. 
Table 9. Causes of breast masses* 
Miscellaneous Fibroadenoma 
Juvenile (giant) fibroadenoma Nipple adenoma 
Other fibroadenoma variants 
Virginal hvoernlasia 
Cvstosarcoma phvllods 
Breast abscess 
Breast cyst (including fibrocystic 
Breast disease and other Breast 
mastopathies) 
Breast carcinoma 
Intraductal papilloma 
Fat necrosis 
Papillomatosis 
Ductal adenocarcinoma 
Mammary duct ectasia 
lntraductal oranuloma 
Sclerosing adenosis 
Keratoma of the nipple 
lnterstitial fibrosis 
Granular cell myoblastoma 
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Lipoma
Lymphangioma 
Hemangioma 
Angiosarcoma of the breast 
Metastatic disease (e.g., 
leukemia, malignant lymphoma, 
ovarian malignancy, others) 
Neurofibromatosis 
Dermatofibromatosis 
Tuberous mastitis 
Papilloma sarcoidosis 
Hematoma 
Others 
• With permission from Greydanus DE. Breast and gynecological disorders" In:  
Hofmann AD, Greydanus DE, eds. Adolescent medicine, 3rd ed. Stamford, 
CT: Appleton Lange, 1997:524. 
Figure 21. Fibroadenoma. Lesions can be diagnosed by needle aspiration and 
effective treatment is total excision. For needle biopsy, use a 11/2-inch 22-gauge 
needle attached to a 12-ml syringe and use aseptic technique. Fix the mass 
between your fingers and place the needle into it. Entering a fibroadenoma, as 
this one, is like placing a needle into a rubber eraser, while entering breast 
cancer, the aspirator notes firm resistance and a characteristic feeling while 
entering microcalcifications of the tumor. A "popping" sensation is felt while the 
needle enters a cyst as the mass disappears.  
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Fibroadenomas are estrogen-sensitive tumors that can develop from 
breast lobules and stroma at any time during adolescence, from 2 years 
before menarche to the more typical late adolescence liming of 17 to 20 
years of age; estrogen receptors are found in this tumor. Development of 
these tumors tends co decrease by the mid-to late 20s (22). It is found in 
all ethnic groups, though it is more common in African-American 
females. Enlargement may occur late in a menstrual cycle and especially 
during pregnancy; spontaneous regression may occur, but is not the 
norm. The typical biopsy reveals a pattern similar to virginal hyperplasia and 
male gynecomastia with ducts that are elongated in a stroma that is 
fibrous (see figures 22-24): a number of histologic variants are noted 
and classified according to tumor size and stroma cellularity (1,2,4). Figure 
25 reveals the ultrasound appearance of  fibroadenomas.  
Used with permission from Jeffrey Pearson. MD. Medical Director, Pathology 
Department, Bronson Hospital, Kalamazoo, Michigan. 
Figure 22. Fibroadenoma Histology. 
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Used with permission from Jeffrey Pearson, MD, Medical Director, Pathology 
Department, Bronson Hospital, Kalamazoo, Michigan Figure 24. Fibroadenoma 
Histology. 
Figure 23. Fibroadenoma Histology. 
Used with permission from Jeffrey Pearson, MD. Medical Director. Pathology 
Department, Bronson Hospital, Kalamazoo, Michigan 
Figure 24. Fibroadenoma Histology. 
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Used with perm1ss1on from Kathleen Gadwood, MD, Ultrasound Division, 
 Radiology Department. Bronson Hospital, Kalamazoo, Michigan. 
Figure 25. Ultrasound: Fibroadenoma. 13 year old, left breast masses. The 
patient presents with two palpable masses in the medial and inferomedial 
left breast. On palpation, these masses are freely movable with a rubbery 
consistency. They are nontender. Targeted ultrasound shows the largest mass 
located medially is oval, well-circumscribed with a thin capsule, long axis 
parallel to the skin, measuring 3.3 x 3.3 x 0.8 cm. This is located in a very thin 
portion of breast tissue. The other nodule is located just medial and inferiorly,  
and measures 1.9 x 1.1x 0.8 cm. This has a similar echo appearance. Impression: 
Benign findings. The sonographic appearance would be consistent with two 
fibroadenomas.  
   Though the differential diagnosis of a breast mass or lesion in an 
adolescent is quire  extensive  (see table 9), the diagnosis of  fibroadenoma 
is usually  considered in typical presentations.   Malignancy is often the 
concern of the patient and her  parents;  fortunately,  this is quite rare in the 
adolescent population and there is no proven link between the  presence 
of a fibroadenoma  and later breast cancer development  (4, 44).  The 
timing of the  tumor  removal varies according to the  tumor's presentation, 
size  (some consider  surgery  only if the tumor size  is  >  2  cm),  concern  of 
the patient and/or parents, how quickly the lesion grows, and other 
factors. It is not possible  to predict the growth of a fibroadenoma;  some 
spontaneously involute over several months, some grow slowly, and 
some remain dormant for many years. 
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Discrete breast masses should almost always be removed in boys and 
postpubertal girls. Excisional biopsies are usually performed using a 
circumareolar incision; if the mass is distant from the areola, an incision 
directly overlying the mass may be performed. A small and slow. 
growing lesion in an adolcscent female that is rubbery and non-tender 
can be observed over 2 co 4 months. Novel non-s1croidal selective 
antiestrogen drugs have also been administered in those with 
fibroadenoma, with a reported result of 40% disappearance and 20% 
partial regression (43,45). Minimally invasive procedures for 
management of fibroadenoma include percutaneous radiofrequency-
assisted excision and cryotherapy ( 46,47). 
One should certainly not wait until the lesion is large, as this 
may require more extensive surgery to remove the tumor, increasing the 
risk of breast deformity, and making skin closure more difficult. Expert 
surgical technique is important for the youth with a young, growing 
breast; for example, protection of the developing nipple, areola, and other 
breast tissue is as important as excision of the lesion. Waiting until the 
tumor is large may also require additional surgery to reduce the skin 
envelope and elevate the nipple for a good cosmetic result. If a unilateral 
lesion presents, excision biopsy can rule out cystic breast disease, 
virginal hypertrophy, cystosarcoma phyllodes and other conditions. A 
lesion that enlarges rapidly must be distinguished from virginal 
hyperplasia, giant fibroadenoma, and cystosarcoma phyllodes. If a 
patient presents with fibroadenomatosis, the largest lesion should be 
removed to establish the diagnosis and prevent breast deformity. If there 
is evidence of malignancy, immediate investigation with complete lesion 
removal is indicated. 
GIANT (JUVENILE) FIBROADENOMA
The giant or juvenile fibroadeaoma is larger than 5 cm in diameter, 
some1imes doubling in size within 3 to 6 months, up to 15 or 20 cm; it 
may compress or replace normal breast tissue (see figures 26 and 27) 
(1,2,4,9). It is less common than the normal fibroadenoma, but, like the 
typical fibroadenoma, the giant variant is more common in African-
American  youth and peaks  in incidence in late adolescence;  it tends to be 
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more common than the smaller version in the young adolescent and its 
consistency tends to be softer than the rubbery consistency of the smaller 
fibroadenoma. Adjacent breast tissue can be compressed and distorted by 
the size and rapidity of growth of a giant fibroadenoma, leading to 
overlying skin ulceration. 
l 
Used with permission from Jeffrey Pearson, MD, Medical Director, Pathology 
Department, Bronson Hospital, Kalamazoo, Michigan. 
Figure 26. Giant (Juvenile) Fibroadenoma. 
Complete removal of a large lesion may be difficult because of its 
size and the difficulty separating out normal tissue margin from tumor 
margin. A number of histologic variants are described and are sometimes 
confused with cystosarcoma phyllodes. The typical biopsy of a giant 
fibroadenoma reports increased stromal cellularity and fibrosis. The 
lesion can be single, recurrent, or even found posterior to breast tissue; in 
the later case, the larger breast has increased warmth because of 
increased blood in the tumor and distended veins overlying the involved 
skin. A tumor with severe atypical epithelial hyperplasia may cause 
confusion with malignancy. 
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Used with permission from Jeffrey Pearson, MD, Medical Director, Pathology 
Department, Bronson Hospital, Kalamazoo, Michigan. 
Figure 27. Giant (Juvenile) Fibroadenoma.  
CYSTOSARCOMA PHYLLODES 
Though breast malignancy  is  rare  in  the  adolescent,  the  main  type  noted 
is   cystosarcoma      phyllodes        (phylloides;      Greek:       phullon leaf) 
(1,2,4,9,14,48,49). Its original description by Muller in 1838 included the 
idea that this tumor arises from a fibroadenoma, leading to many decades 
of linking these two lesions (1,2). At present, there is no evidence 
cystosarcoma phyllodes arises from a fibroadenoma. Proposed etiologic 
factors for cystosarcoma phyllodes include pubertal hormonal effects 
(including excess estrogen), pregnancy, lactation, and trauma. It can be 
associated with a variety of tumors, such as intraductal breast carcinoma, 
Brenner tumor of the ovary, desmoid tumor, and scirrhous breast 
carcinoma. 
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Cystosarcoma phyllodes can be found in all decades of life, peaking 
in the fom1h decade. In adults it represents 0.3 to 0.9 percent of all breast 
tumors and though most are benign, metastatic disease is found in 3% to 
12% (or more). Approximately 5% to 8% of cases occur in those under 
age 20, mainly between ages 16 and 19 years of age and most are benign 
(1,2,48). However, rare cases of malignant disease with death are 
reported in the literature in adolescent females as well as cases of 
cystosarcoma phyllodes in prepubertal children and even adolescent 
males with gynecomastia.  
Cystosarcoma phyllodes usually presents as a painless, slow growing 
breast tumor that is typically 8 cm to 10 cm when found. However, its 
growth may be explosive and symptoms are dependent on the size and 
location of the tumor. There may be a large tumor (up to 20 cm) with 
overlying shiny skin that is stretched and contains distended veins, 
erythema, and skin ulcers. There can also be local tissue compression 
(with parenchyma necrosis), nipple retraction, bloody nipple discharge, 
and in 20% of cases-axillary lymphadenopathy (from infection and 
tumor necrosis, not usually overt metastasis). In the unusual adolescent 
case with tumor metastasis, spread is hematogenous and the lung is the 
most common area involved, though any organ invasion is possible. The 
tumor size does not reflect malignancy and three basic histologic patterns 
are described: benign, intermediate (borderline), and malignant. 
A benign type has less encapsulation and more cellular stroma than a 
fibroadenoma; a malignant lesion has cellular atypia, anaplasia, and 
mitotic activity. 
An ultrasound may give a fibroadenoma-like appearance or give a 
cystosarcoma phyllodes-like appearance of fluid-filled, elongated spaces 
or cleft  within a solid tumor. As previously noted, mammograms are 
usually not helpful in adolescent females because of their dense breast 
tissue. Management depends on total rumor removal, results of the 
histologic study, and evidence of metastasis. The tumor must be fully 
excised, leaving margins free of tumor and tumor appendages. 1l1e 
management of intermediate or overt malignant cases remains 
controversial and the prognosis is often poor. Various treatments are used 
including radical surgery, chemotherapy, radiation therapy, and 
hormonal trea011ent ( 1,2,4,9,14,48,49). 
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INTRADUCTAL BREAST PAPILLOMA 
This is a rare tumor in the adolescent population, usually presenting as a 
small lesion under the areola that produces sanguineous or sero- 
sauguineous discharge from the nipple (1,2,4). It may be quite small and 
only found with careful palpation in the subareolar area. Sometimes a 
tumor is not felt, but palpation compresses a duct that is distended with 
the tumor, leading to the typical nipple discharge. lntraductal breast 
papilloma is bilateral in 25%, and cytology of the nipple discharge notes 
clusters of ductal cells. Table to lists the differential diagnosis of 
intraductal breast papilloma. Helpful diagnostic aids include ultrasound 
and fine needle aspiration. Intraductal breast papilloma is a benign lesion 
(though some experts classify it as a pre-malignant condition) and local 
excision cures the condition. Infiltrating ductal adenocarcinoma is a very 
rare malignant disorder in adolescents that requires radical mastectomy 
and radiation therapy. 
Table 10. Differential diagnosis of intraductal breast papilloma 
Fibroadenoma 
Nipple adenoma  
Cystosarcoma phyllodes 
Papillary carcinoma 
Mammary duct ectasia 
Ductal hyperplasia 
Juvenile papillomatosis with cystic lesions 
Papillary duct hyperplasia (non-cystic lesions) 
-Solitary papilloma
-Papillomatosis (epitheliosis)
-Sclerosing papillomatosis
-Multiple papillomas 
Infiltrating ductal adenocarciooma 
Mammary duct ectasia (periductal mastitis) presents with a nipple 
discharge (dark-brown) because of dilatation or ectasia of ducts behind 
the nipple; there can be a painful subareolar nodule with nipple 
retraction, sinus tracts or fistulae, and axillary lymphadenopathy. It is the 
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most common cause of nipple inversion and there can be infection with 
Bacteroides sp. Management includes antibiotics, sinus tract/fistulae 
excision and sometimes, excision of part or all of the involved nipple. 
BREAST CANCER 
Breast cancer (i.e., adenocarcinoma) is a rare disorder in adolesccnt 
females; however, it is on the mind of the patient (and parents) when she 
presents with a breast mass (1,2.4,50-53). Breast cancer is found in less 
than 2% of females under age 25, less than 1 % in those under age 20 
years of age, and rarely in those under 15 years of age. However. it is 
reported in youth and very rarely in prepubertal children, and thus, must 
be part of the differential diagnosis of a breast mass in children and 
adolescents. In very rare cases it has been reported in males (52,54,55). 
Risk factors are noted in table 11 and improved prognostic factors in 
table 12 (1,2,9,14,56). A positive family history for breast cancer is a 
very high risk factor (30-50%), especially with certain syndromes, as 
noted in table 9. Those with BRCA1 or BRCA2 gene mutations are noted 
in 8 of 10 familial breast cancers and 5% of all breast cancers (1,2,9,56). 
The decision to test for these gene mutations in female adolescents with a 
positive family history for breast cancer is based on various factors 
including the age of the adolescent, legal consent issues, and others. 
Though controversial, there is no clear link between the use of oral 
contraceptives and later development of breast adenocarcinoma (57). 
However, breast cancer is found in association with other cancers, as that 
of the ovary, uterus, and colon. Two-thirds of breast cancer found in 
adolescents are malignancies arising in non-breast tissue, such as 
secondary sarcomas (fibrosarcoma or liposarcoma) and metastatic 
disease due to lymphoma, leukemia, Hodgkin's disease, or multiple 
myeloma (57,58). 
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Table 11. Risk factors for breast cancer* 
Positive family history of breast cancer Nulliparous status;  not breast-feeding 
    -BRCA L (chromosome 17 q)                                              Benign breast disease (see text)
   -BRCAZ(chromosome 13 q)                                   Hormone replacement therapy 
(HRT) 
(especially HRD 
      ?Oral contraceptive pill? 
Miscellaneoos syndromes       Delay of first pregnancy (after age 30) 
SBLA Syndrome (Li-Fraumani)              Radiation exposure 
(especially the chest) 
Cowdcn's Syndrome                                  Increased dietary fat 
(proposed) 
Muir Syndrome                                         Obesity (proposed) 
Klinefelter syndrome (males) 
Others
consumption 
Early puberty and early menarche 
(as Hodgkin's disease) 
Moderate or more alcohol 
History of childhood cancer 
• Used with permission from: Greydanus DE, l'arl(s D, Farrell E. Disorders of 
!he breasts in children and adolescents. Pediatr Clin North Am 1989;36(3}:625. 
Table 12. Good prognostic factors for breast cancer* 
Stages I and II 
(Stage I: tumor is under 2 cm in diam.eter and there are JlO lymph 
nodes or distant metastasis: Stage II: tumor is under 5 cm in 
diameter. the palpable lymph nodes are not fixed, and there is 
no distant metastasis). 
Positive estrogen rece.ptor status 
Secretory histology type 
Circumscribed tumor edge (versus infiltrative) 
Lateral location (versus medial) 
Tumor under 2 cm in diameter 
Absence of lymphadenopathy, nipple involvement, and cutaneous 
inflammatory changes 
•Used wilh permission from: Greydanus DE, Parks D, Farrell E. Disorden; of the 
breasts in children and adolescents. Pediatr Clin North Am 19&9;36(3):625. 
* Used with permission from: 
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Though breast cancer is rare in the adolescent., it does exist and this 
risk increases considerably as she enters her adult years (see figure 28). 
Issues of self-breast examinations in adolescent females have been 
considered earlier. Screening mammograms are not helpful in most youth 
because of their normally dense breast tissue, as previously noted (see 
figure 29). The role of prophylactic mastectomy for those considered at 
high breast cancer risk should be made in consultation with a 
gynecologist recognized in this area; it is a controversial step, but one that 
patients can consider. Adult females with benign breast disease that 
increases their risk for breast cancer may be offered prophylactic 
tamoxifen (22). 
Adenocarcinoma presents in the adolescent female as a non-tender, 
indurated, hard, single mass; it has indistinct margins, is typically fixed 
in the breast tissue or chest wall, and ranges from 1 cm to 9 cm at 
discovery. There may be skin edema, (peau d'orange), nipple discharge, 
retraction o f  the skin or nipple, and/or lymphadenopathy (axillary or 
supraclavicular). Metastatic disease may induce generalized skin rash, 
dyspnea (with pleural effusion), upper or lower limb swelling, back pain, 
hepatomegaly, and/or other features indicating spread of the primary 
cancer. A variety of diagnostic procedures are used, including 
mammography, ultrasonography, thermography, and DTPA breast 
scintiscanning. A CT or MRI can be helpful to differentiate a breast mass 
from a rib le-sion or other chest wall pathology, or identify normal tissue 
(versus a mass, including a hemangioma or lymphangioma). The most 
reliable way to differentiate breast cancer from more common benign 
breast masses is the triple assessment, including palpation, radiology 
(mammography, ultrasound, and MRI scan), and fine-needle aspiration 
cytology (59). 
An open or closed biopsy obtains tissue for a definitive pathological 
diagnosis, noting whether the cancer has developed from the secretory 
part of the breast (lobules) or the duct connecting the lobules to the 
nipple; it can be invasive or in situ. As noted, the cancer is an 
adenocarcinoma, often secretory, though other types are also less 
frequently identified (i.e., papillary, medullary, infiltrative, serous, 
glandular, inflammatory, colloidal, and mixed). Metastatic disease may 
develop, involving bone (often the back), lungs, liver, and other sites; it 
can be monitored with a variety of biochemical markers,  such as 
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carcinoembryonic antigen, alkaline phosphatase, and hydroxyproline. 
Breast sarcomas and secondary malignancies (from leukemia or 
malignant lymphomas) are rarely noted as well. There may be a second 
cancer in an adolescent whose first cancer (i.e., leukemia, non-Hodgkin's 
lymphoma) occurred when the patient was a child, a metastatic 
neuroblastoma, a cancer due to previous chest wall radiation, and others. 
Management should be under the care of a specialist trained in current 
techniques of treatment, as well as understanding of the adolescent 
patient and her family.   
Figure 28. Breast Cancer. 
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Figure 29. Breast Anatomy and Mammography.  
BREAST INFECTIONS 
Pre-pubertal infections 
Neonatal breast hyperplasia can be complicated by infection from too 
much clinician examination or over-manipulation, as noted earlier. 
Mastitis can develop in neonates (mastitis neonatorum) involving the 
entire breast bud and can be complicated by septicemia (1 ,4,9).  Mastitis 
can also develop in the prepubertal child, though septicemia does not 
usually occur. Antibiotic therapy is important to help resolve this 
infection in both newborns and children. The most common organism 
causing breast abscesses in this population is Staphylococcus aureus. 
Recently, an increasing number o f  skin and soft tissue abscesses caused by 
community-acquired methicillin-resistant Staphylococcus aureus 
( M R S A  and other variations) have occurred in children. 
Treatment involves antibiotics, needle aspiration, or surgical 
drainage. The literature suggests that drainage alone. without adjunctive 
antibiotics, may be effective for skin and soft tissue abscesses caused by 
M R S A ;  no  definitive  antibiotic recommendation exists regarding  M R S A 
288             Donald E. Greydanus, Hatim A. Omar, Lyubov Matytsina et al. 
breast abscesses (60). If an incision and drainage-procedure is used, a 
circumareolar incision is recommended to avoid damage to the breast 
bud tissue, leading to later reduction iJ1 adult breast size; it is also 
important to avoid removing the entire breast bud, which can happen, if 
concern is raised about a "lesion" that may be the breast bud!
Post-pubertal infections: Lactational mastitis 
Breast infection or mastitis in the adolescent usually is noted during 
lactation, but also can be due to trauma (including sexual, areolar hair 
pulling [leading to a Montgomery tubercle abscess], squeezing an acne 
lesion, piercing), duct abnormality (as duct ectasia), or reduced immune 
defenses due to chronic illness (1,4,5,9). Mastitis develops to some 
degree in about  2%  of  pregnant  women (lactational mastitis), usually in 
the postpartum period and less commonly, during pregnancy itself. 
Mastitis during lactation can be classified as an obstructive mastopathy, 
in which a major breast duct(s) becomes plugged leading to milk stasis, 
and secondary infection (due to Staphylococcus aureus [80%-90%], 
Streptococcus pyogenes, Micrococcus pyogencs, Escherichia coli, 
Pseudomonas aeruginosa, and others [as Mycobacterium tuberculosis]). 
Nipple trauma may also lead to infection. The same organism can be 
seen in the other, asymptomatic breast of the lactating female, as well as 
the pharynx of her infant. Milk from the infected breast may have an 
increased leukocyte count. 
The infection usually develops with sudden onset of swelling, 
erythema, and tenderness; the skin is often warm to the touch in 
association with local cellulitis, regional lymphadenopathy, and if an 
abscess results, fluctuance develops. Extensive spread of the infection is 
usually limited by normal breast support tissue. including Cooper's 
ligaments; however, sometimes the support tissue can mask an abscess. 
Extensive breast tissue damage can result from large breast abscesses, 
usually developing in cases without proper management. The differential 
diagnosis of mastitis is listed in table 13. If mastitis does develop in an 
adolescent, pregnancy should be considered. Supportive laboratory 
studies include a needle aspiration with cultures, ultrasound, and 
possibly, blood cultures. 
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Table 13. Differential diagnosis of breast mastitis 
Lactational mastitis 
Non-lactational mastitis 
Mondor's disease  
Mammary duct ectasia 
Recurrent subareolar abscess 
Trauma (sexual and non-sexual) 
Breast malignancy 
Management of mastitis in cases of milk stasis (with no associated 
infection) is by the use of warm compresses and continued breast 
feeding, as well as pumping out extra-produced milk, until normal 
balance is established between production and consumption. Antibiotics 
are used in cases of infection in order to cover the expected bacteria that 
are seen in such infections (1,2,4,5,9). A variety of antibiotics have been 
used for 2 to 6 weeks, including amoxicillin, amoxicillin-clavulanic acid, 
erytbromycio, B-lactamase-stable penicillin [i.e., dicloxacillin], or a 
cephalosporin (i.e., cephradine or cephalexin); if  fluctuance develops, 
incision and drainage of the abscess is necessary, using a circumareolar 
incision; the clinician should be suspicious of an abscess if antibiotics do 
not improve the initial infection (5,60). Antibiotics (sometime given 
intravenously) are continued until the infection is resolved, including 
resolution of the pain and cellulitis. If outpatient treatment with these 
antibiotics are not helpful, consider the possibility of an abscess and use 
metrooidazole or intravenous vancomycin (or other antibiotics) (61). 
Complications include recurrence (50% in a breast abscess), breast 
necrosis or scarring [sometimes mistaken for a fibroadenoma], and in 
rare cases, septicemia. Breast feeding is continued unless purulent 
discharge develops. Ultrasonography can successfully help evaluate 
follow-up results.  
Non-lactational-nonpuerperal mastitis 
Non-puerperal mastitis is rare and its cause not known (see figures 30 
and 31); its presentation is similar to that of lactational mastitis. There 
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may be known precipitating factors, such as trauma (including sexual 
foreplay and nipple piercing), duct ectasia, epidermal cysts, local skin 
infections, cystic breast disease, abscess of the Montomery's glands or 
other sebaceous glands, syphilic chancre or gumma, tuberculosis, 
Wegener's granulomatosis, fungal infections, and protozoan infections. 
Figure 30. Mastitis, Right Breast in  a 12 year old girl.  
Management of bacterial mastitis, as already noted, includes warm 
compresses, antibiotic coverage, and sometimes, surgical drainage of the 
abscess. Table 13 reviews the differential diagnosis of mastitis, including 
Mondor' s disease, a usually benign condition characterized by superficial 
phlebitis in the breast skin; it typically develops after trauma (such as a 
biopsy or sports trauma), though sometimes the precipitating event is not 
identified. Mondor's disease presents with tender cords of inflamed veins 
that can be palpated, and usually resolves spontaneously, with or without 
mild analgesics (62). 
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Figure 31. Staphylococcal Breast Abscess. 
Body piercing in general has become more common in both female 
and male adolescents over the past decade. Cases of nipple piercing as 
the cause of local infection and disfiguration have been reported (4). 
Staphylococcus and Streptococcus species are the common causative 
organisms in these situations, but cases of Mycobacterium have also been 
noted. Treatment includes appropriate antibiotics and removal of the 
foreign body.  
SPORTS-INDUCED BREAST TRAUMA 
Nipple trauma 
The nipple is a common site of injury, especially in female athletes, 
because it is the most prominent part of the breast (1,2,63,64). Coarse 
clothing (such as tight-fining brassieres or shirts) can lead to an acute or 
chronic abrasive injury to the nipple, particularly during jogging or other 
actions, resulting in strong, repetitive nipple nibbing. It has been called 
jogger's nipple or bicyclist's nipple, the latter described in bicycle 
athletes who ride in cold wind and develop a raw, painful, bleeding 
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nipple (s). Cold exposure or direct nipple stimulation affects local nipple 
muscle fibers, inducing an erect, prominent nipple. There is a 20: 1 ratio of 
males to  females with nipple injury in long-distance runners. The 
differential diagnosis of such nipple disease includes sports-induced 
trauma, intraductal papilloma, and carcinoma. Sports-induced nipple 
injury is assessed with prevention of further nipple trauma and treatment of 
any secondary infection. Prevention of nipple injury during exercise or 
sports is listed in table 14.   
Table 14. Prevention of sports-induced nipple injury* 
1. Use a plastic bandage (ie, a Band-Aid) or  petroleum jelly 
(Vaseline) before and during the exercise
2. Use a properly fitted sports brassiere
3. Avoid exposure to cold temperatures 
4. Use wind breaking material over the chest 
5. Special attention during pregnancy, when nipples are more 
prominent  
*Used with permission from: Greydanus DE, Patel DR.: The female athlete:
         Before and  beyond Puberty. Pediatr Clin North Am 2002;49:553-80. 
Breast trauma  
Though fortunately not a common occurrence, sports-induced trauma to 
the breasts can occur, leading to breast contusions, lacerations or 
hematomas (63,64). Trauma often may occur during sports activity such 
as basketball or volleyball, but are noted in other sports a  well. 
Contusions are due to superficial capillary rupture with ecchymosis along 
with edema, are usually mild, and may take up to three weeks to resolve. 
Abrasions result from various sports-related trauma, such as bicycle 
accidents (i.e., road racing, mountain biking), rodeo events, siding, or 
baseball (i.e., from sliding). Parts of the female's bra may induce injury 
because of bra clips, underwire metal hooks, clips or straps. Lacerations 
may occur as well. and proper closure is impor1.ant; observing for the 
development of a secondary abscess that can be painful is also part of the 
evaluation and follow-up. 
Breast Disorders in Children and Adolescent  293 
Hematomas can develop from a strong blow to the breast that causes 
bleeding from blood vessels deep in the breast tissue. Fat necrosis may 
later develop with secondary induration, scarring, and calcification 
lasting for many years and being confused with breast carcinoma. 
Fortunately, most breast hematomas resolve spontaneously, though some 
require surgical aspiration. Table 15 reviews basic management of these 
trauma-induced breast inju1ies. Sports-induced injuries can be reduced 
with the use of a properly fitting sports brassiere. This should be 
especially designed for athlete use and is made of cotton material; regular 
replacement is important, no later than every 6 months. 
Table 15. Management of trauma-induced breast injuries*
3.   Laceration 
a. Close with steri·strips or sutures 
b. Use good hygiene principles
c. Apply a firm post-closure dressing
d. Advice for the use of a supportive (sports) brassiere
(including at night) 
e. Pain and swelling can be reduced with a cold pack 
f. Provide a tetanus toxoid if warranted 
g. Antibiotics may be needed, depending on the situation  
4. Hematoma
a. Most resolve without treatment 
b. Surgical aspiration may be necessary 
*Used with permission from: Greydanus DE. Patel DR.: The female athlete: 
Before and beyond puberty. Pediatr Clin North Arn 2002;49:553-80. 
1. Contusion
       a.      Application of cold (ice) every 15-20 minutes--several   
                hours; do not apply ice directly to the skin but with a                  
                protective barrier.
       b.      Appropriate analgesia
       c.      Firm support
2. Abrasion
       a.      Direct pressure to control bleeding 
       b.      Suturing may be necessary
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BENIGN BREAST DISEASE 
Breast tissue is made up of epithelium, adipose tissue, and connective 
tissue. Breasts can normally be nodular during the childbearing years, 
with considerable cyclic volume changes. as much as 50% during a 
menstrual cycle. The adolescent is at the beginning of breast changes that 
will continue over several decades and there can be some confusion 
between normal changes on the one hand, and benign breast disease on 
the other (1,2,9). Cyclic changes in the breast that reflect physiologic 
changes are normal and should not be labelled as a disease state. Thus, 
there can be a variety of changes, including physfologic (cyclic) swelling 
and tenderness (possibly part of PMT/ PMS), nodularity or significant 
lumpiness (cyclic or noncyclic), mastalgia (cyclic or noncyclic), and 
various dominant breast cysts or lesions (1,2,9,14,22,65-71). 
Benign single or multiple cysts are noted in adolescents, though not as 
commonly as a fibroadenoma is noted in adolescent females. These 
benign cysts arc typically not fixed to breast tissue and contain different 
amounts of sterile fluid that can be clear, brownish, or blood-tinged. 
Table 16 provides a partial classification of these benign cysts. A solitary 
large cyst (macrocyst or "blue-domed cyst") contains fluid with various 
colors (green, yellow, or black) that can be confused with a 
fibroadenoma or breast cancer; it is usually fluctuant, but can be hard or 
tense. Fine-needle aspiration (FNA) with cytology reveals the benign 
nature of the cyst and usually there is no recurrence (68,69).  
Table 16. Types of benign breast cysts 
Fibrocystic change 
Solitary large ("blue-domed") cysts 
Simple single cyst  
Galactoceles 
Pseudolumps (normal physiologic changes) 
Traumatic fat necrosis 
Others 
   During lactation, galactocele(s) can develop from overdistention of 
lactifcrous  duct (s), usually presenting  as   a  subareolar  mass  with  a  yellow 
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discharge. The mass is excised if it does not disappear with continued 
lactation. Trauma to the breast can lead to the appearance of areas of fat 
necrosis in the breast. 
A fine-needle aspiration of a cyst can be done testing for the 
presence of red blood cells (with a guaiac test) and abnormal cells 
(Papanicolaou fixative for cytology). If the mass disappears after 
aspiration, it is usually called a cyst and reexamination occurs in 2 to 3 
months. If the mass reoccurs (as noted in as many as 50%), ultrasound 
imaging  can be obtained,  as well as ultrasonically-guided  aspiration with 
a pneumocystogram to evaluate the cyst walls (70). Air can be injected 
into  the cyst wall to decrease the risk of cyst recurrence.  If  the aspiration 
is non-diagnostic or possible, an excisional (open) biopsy can then be 
done under local or general anesthesia, in order to obtain more 
information about the lesion. Figure 32 shows the ultrasound image of a 
benign breast cyst, figure 33 reveals the ultrasound image of a breast 
hemangioma, and figure 34 notes a "breast lesion" that was actually an 
axillary node. 
Used with permission from Kathleen Gadwood, MD, Ultrasound Division, 
Radiology Department, Bronson Hospital, Kalamazoo, Michigan . 
Figure 32. Ultrasound: Benign Breast Cyst. In the medial upper left breast. 
There is a simple 1.2 x 0.7 x 1.1 cm cyst. Scanning also reveals a cyst at about 12:00 
position in the left breast measuring 2.3 x 0.9 x 2.1 cm. 
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Figure 33. Ultrasound: Left Breast. Mass, 3-month-old. On Visual inspection, 
there is swelling of the tissues involving the left breast area. This feels soft on 
palpation. There is a bluish discoloration through the skin. Ultrasound scanning 
targeted here shows a hypoechoic mound-shaped area of tissue behind the areola, 
without discrete borders. Color Doppler readily demonstrates multiple blood 
vessels composing this mass. The vessels represent a combination of arteries and 
veins. The bulk of the soft tissue swelling seems to be caused by enlarged 
vessels. There are no other nonvascular spaces 10 suggest lymphatic tissue. This 
does not have the appearance of gynecomastia. Impression: Left breast mass is 
consistent with hemangioma or other vascular malformation. This does not look 
like a lymphangioma or soft tissue mass from a neoplasm.  
Fibrocystic change 
        Formerly  called  fibrocystic  disease,   the  term  fibrocystic  change  is 
used   to   refer   to   hormonal-induced    breast   changes   that   are   more 
physiologic  in   nature   than  overt  disease.   Though   more  common  in 
females in their third decade of life  and  beyond,  adolescent  females  may 
present  with   various  degrees  of  breast  tenderness  and  nodularity  that 
Breast Disorders in Children and Adolescents 297 
tends to change over the course of the menstrual cycle. Diffuse cord-like 
thickenings and lumps may develop over time, while some patients 
present with vague lumps or nodules (1,2,9,22). The second most 
common breast lesion in adolescents after the fibroadenoma is fibrocystic 
change (72). The etiology is unclear and often linked to estrogen and 
progesterone imbalances. Biopsy of these lesions reveals alveoli and 
terminal ducts with secretory material that are the basis of cystic 
development (57) (see figures 35-37). Some forms of benign breast 
disease (as cystic disease, atypical ductal or lobular hyperplasia, 
proliferative changes, others) are listed as risk factors for later breast 
cancer in the adult years (4,17,72,73). 
Figure 34. Left Breast Lump. Scanning of tl1e left breast lump (upper outer 
aspect of breast) demonstrates a 1.2 x 0.5 x 1 cm lymph node. Vascular hilum 
noted.  No other  suspicious findings are noted.  Impression:  Approximately 12 x  5  
x 11 mm lymph node that corresponds to the left breast palpable finding.  
298                   Donald E. Greydanus, Hatim A. Omar, Lyubov Matytsina et al. 
Used with permission from Jeffrey Pearson, MD. Medical Director, Pathology 
  Department, Bronson Hospital, Kalamazoo, Michigan.  
Figure 35. Fibrocystic Change Histology. 
Used with permission from Jeffrey Pearson, MD, Medical Director, Pathology 
Department, Bronson Hospital, Kalamazoo, Michigan. 
Figure 36. Fibrocystic Change Histology.  
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Used with permission from Jeffrey Pearson, MD. Medical Director, Pathology 
Department Bronson Hospital, Kalamazoo, Michigan. 
Figure 37. Fibrocystic Change Histology.   
Management depends on the severity of the condition and starts with 
reassurance of its benign nature, use of a well-fitting (sports) brassiere to 
prevent inflammation as well as stretching of breast ligaments, cold 
compresses, and a trial of mild analgesics (such as ibuprofen (other non-
steroidal anti-inflammatory drugs) or acetaminophen). In more severe 
conditions, oral contraceptives are beneficial in as many as 90% of 
patients, by reducing overt cystic breast production. Some medications 
have been used to manage fibrocystic change in adult women and include 
danazol, bromocriptine, and tamoxifen. These drugs have no proven 
value in adolescent females and introduce possible adverse effe c ts, 
including teratogenicity and masculinization. Primrose oil may be 
beneficial at 3 to 4 grams per day (72). There is also no proven value for 
anecdotal management such as limiting methylxanthine (caffeine) 
ingestion or adding such substances as vitamin E or calcium (72). 
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Breast pain (mastodynia; mastalgia)  
Mastodynia   often   refers   to   breast   pain   that   develops   as   part   of 
physiologic swelling  and  nodularity of breast tissue occurring on a cyclic 
or non-cyclic basis (1,2,4,9,14,22.57,74,75). It may develop or worsen 18 
to 24 months after menarche and may, in some cases, he associated with 
episodes of breast hyperplasia (mammary dysplasia). Breast pain is 
observed in as many as 40% of reproductive age females and nearly 10% 
have their daily activity affected as a result (57). It may be part of a 
premenstmal tension syndrome (PMS), fibrocystic change, or related to 
such precipitants as pregnancy, infection. trauma, or medications 
(including oral contraceptives or other oral estrogen administration, 
phenothiazines, marijuana, others). Drugs that can lead to galactorrhea or 
gynecomastia can also cause breast pain (57). It is also irnportant to rule 
out other causes that may be confused with breast pain, such as chest  
wall pain (Tietze syndrome or osteochondritis), cervical spine disease, 
cardiac disease or others (1,2,9,22). Thus, a careful assessment is 
necessary to identify the u11dcrlying cause of the pain.  
Management of breast pain depends on its etiologic process (66). 
Mastalgia that seems to be related to menstrual cycle changes is usually 
mild and reassurance of its benign nature may be all that is necessary 
along with firm brassiere support and possibly. the use of mild  
analgesics. Underlying precipitating factors, such as marijuana or other 
drug use. should be eliminated. Oral contraceptives may improve (or 
worsen) breast pain and some females report anecdotal improvement 
with avoidance of methylxanthines (i.e., caffeine in cola, tea. coffee),  
chocolate. and dairy products. 
The addition of evening primrose oil (y-linolenic acid) capsules (3 
grams per day) is noted to help some females with cyclic mastalgia [61]. 
Vitamin E supplementation (600 IU per day of alpha-tocopherol) has 
anecdotal but no research-based support for improvement. Chasteberry is 
the fruit of the chasteberry tree that is found in western Asia, southwest 
Europe. and the southeastern United States. Chasteberry has been used 
for over many centuries for relief of various gynecologic symptoms and 
some authors note improvement in breast pain from taking chasteberry 
(76,77). 
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Some investigators have reported on the use of mastodinon for mild 
mastalgia and PMS (78). Danocrine is an anti-gonadotropin agent that is 
used by some clinicians to manage adult women with severe mastalgia; 
it has no proven benefit in adolescent females and its administration 
presents a number of potential severe adverse reactions, including 
teratogenicity, androgenization (with hirsutism), acne, weight gain, and 
others. Clinicians should always remember the classic dictum, primum 
non nocere (first, do no harm!). 
GYNECOMASTIA
Visible or palpable mammary glaJ1d development in males is called 
gynecomastia, a term introduced by the famous physician, Galen, in the 
2nd century AD (4,14,79-81). In the newborn male it is called neonatal 
breast hypertrophy, as reviewed earlier. In prepubertal or pubertal 
gynecomastia, the subareolear enlargement is noticed starting at a 
diameter of 1 1/2 or 2 cm and usually reaches 3 cm, though much larger 
growth may occur; it can be unilateral, bilateral and/or familial. The 
tissue is usually firm, though it may blend into the surrounding tissue 
making differentiation from adipose tissue difficut Gyoecomastia is 
found in as many as two-thirds of males between Tanner Stage 2 and 4, 
usually beginning as a unilateral condition that eventually becomes 
bilateral. The breast swelling is often painful at presentation, and some 
youth complain of chest discomfort that may interfere with sports 
activity, including the development of nipple irritation (Jogger's Nipple) 
(63,64). The etiology is usually postulated as an imbalance between 
estrogen and androgen along with issues involving end-organ response to 
hormonal changes. Histology reveals a pattern of connective tissue 
stroma with infrequent lactiferous duct tubules. 
Most cases of gyuecomastia in young adolescent males are termed 
physiologic or idiopathic and resolve within 6 to 18 months (sometimes 2 
years) (see figure 38). The evaluation should rule out pseudo-
gynecomastia (i.e., appearance of breast enlargement that is really due to 
muscle development or obesity) and organic causes, as noted in table 17. 
Clinicians should he especially concerned about the development of 
breasts in males apart from Tanner stage 2 to 4 time period or if other 
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problems are noted, such as history of estrogen ingestion, finding of 
small testicles, and others, as noted in table 18 (see figure 39). Breast 
manipulation may lead to galactorrhea. Breast cancer is very rare in 
males; however, there is an increased risk of breast cancer in those with 
Kleinfelter syndrome and those with a familial history of 
BRCA-2 mutations (2,56). There is also an increased incidence of prostate 
cancer in those with a history of BRCA-1 mutation (see figure 40). 
Figure 38. Gynecomastia in an. Adolescent. B. Lateral View. 
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Figure 39. Gynecomastia in an Adult 
Used with permission from Kathleen Gadwood, MD, Ultrasound Division, Radiology 
Department, Bronson Hospital, Kalamazoo, Michigan.  
figure 40. Breast Ultrasound. History of right nipple/subareolar enlargement, renal 
failure on dialysis, and hypertension in a 16 year old male. Ultrasound scanning 
shows an oval mound of uniform tissue in the right subarcolar area which measures    
3.3 by 3 .6 by 0.9 cm. This seems to be: some focal glandular tissue. It is larger than  
on the left side, where the tissue measures 2.2 by 2.2 by 0.5 cm. There is no abnormal 
mass, no cystic change. Impression: The palpable fullness on the right is consistent   
with gyoecomastia. 
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Table 17. Causes o f  type II gynocomastia* 
Idiopathic 
Familial 
A ssociated with anosmia and 
testicular atrophy 
Reifenstein's syndrome 
Associatcd with hypogonadism and  
a small penis 
Others 
Klinefelter syndrome 
Male pseudohermaphroditism             
Androgen insensitivity syndrome 
(Testicular feminization syndrome) 
Tumors (seminoma, Leydig cell tumor, 
teratoma, feminizing adrenal tumor, 
hepatoma, bronchogenic carcinoma) 
Leukemia 
Hemophilia 
Leprosy 
Thyroid dysfunction (hyper- and 
hypothyroidism) 
Cirrhosis of the liver 
Traumatic paraplegia 
Chronic glomerulonephlitis       
Starvation (on refeeding) 
Miscellaneous drugs 
Amphetamines 
Anabolic steroids 
Birth control pills      
Busulfan (and other 
chemotherapeutic agents) 
Cimetidine 
Clomiphene 
Corticosteroids 
Digicatis 
Etretinate 
Estrogens 
Human chorionic 
gonadotropin 
Insulin 
Isoniazid (and other 
antituberculosis drugs) 
Ketoconazole              
Marijuana 
Methadone 
Reserpine             
Spironolactone 
Testosterone 
Tricyclic antidepressants 
Others 
* Used with permission from: Greydanus DE, Parks D, Farrell E. Disorders of
the breasts in children and adolescents. Pediatr Clin North Am  
1 989;36(3):634.  
History 
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Table 18. Evaluation of gynecomastia 
Timing of breast appearance 
Family history 
Systemic disease history 
Weight changes 
Use of drugs or medications 
Physical Examination 
Vital signs (height, weight, blood pressure) 
Breast development (Tanner Stage and breast size)  
Genitals (Tanner Stage and any abnormality of the genitals) 
Neurologic examination. 
Laboratory Studies (Serum) 
LH,FSH 
Testosterone (free. total) 
Estradiol 
SHBG (sex hormone hinding globulin) 
HCG 
17-urinary ketosteroids 
DHBA-S 
Androstenedione 
Prolactin 
Karyotype 
Others 
Management of idiopathic gynecomastia with breasts under 3 cm is 
usually reassurance that it is a "normal" occurrence, with further 
reassurance that he is not "feminine" or "turning into a female," and 
watchful waiting while the breast tissue resolves. If he is obese, measures 
for weight reduction may be helpful as well. Medications used for some 
adults with gynecomastia (i.e., antigonadotrophic agents [danazol], 
estrogen antagonists [clomiphene, tarnoxifen], or aromatase inhibitors 
[testolactone]) are. not recommended for adolescents since they have no 
proven efficacy, have potentially serious side effects, and the breast 
development returns when the drug is stopped. Underlying disorders 
306         Donald E. Greydanus, Hatim A. Omar, Lyubov Matytsina et al. 
should be treated,  as for example,  testosterone  replacement  for a youth 
with small testes due to Kleinfelter Syndrome. 
Large breasts (Tanner Stage 3 or 4 as well as over 4 cm) are unlikely 
to fully resolve spontaneously. After two years of any size breasts, 
resolution is unusual because of the development of stromal fibrous 
tissue (57). Thus. the patient can be managed with surgery (i.e., 
periareolar incision and suction lipectomy or reduction mammoplasty) 
(4). Even males with small breasts may have severe emotional reactions 
to their breast development and should be offered surgery if necessary. 
NIPPLE DISCHARGE 
Nipple discharge can be caused by many factors and disorders, as listed 
in table 19; the basic categories of etiologies are idiopathic, drug- 
induced, neurogenic, and endocrine/hormonal (including hypothalamic 
and pituitary disorders) (1,2,4,9,14,22,57,82-84). The evaluation of  
nipple  discharge looks at the nipple secretion (color and amount),  history  
of trauma (including breast manipulation), breast disorders, or menstrual 
abnormalities. The physical examination in a female with nipple 
discharge involves a careful breast examination, including nipple 
palpation. A ductogram (galactography) may be helpful in identifying 
underling pathology, while surgery may be necessary to pinpoint the 
etiology of a breast lesion or remove an offending breast duct. Apocrine 
chromhidrosis refers to colored sweat secretion by periareolar apocrine 
glands. 
Table 19. Causes of nipple discharge 
1. Milky discharge 
a. Lactation
b. Breast cancer
c. Phenothiazine
d. Pituitary microadenoma
e. Elevated TSH (hypothyrnidism)
f. Acromegaly 
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2. Yellow discharge 
a. Galactocele
b. Physiologic effects
3. Serous, clear or greenish discharge: Physiologic Breast Cyst 
4. Bloody discharge   
a, Cystic ductal hyperplasia 
b. lntraductal papilloma 
c. Cystosarcoma phyllodes 
d. Papillary carcinoma  
5. Brownish discharge 
a. Montgomery's gland secretion 
b. Intraductal papilloma 
6. Purulent discharge: mastitis or breast abscess  
GALACTORRHEA 
Galactorrhea refers to breast milk secretion apart from birth or abortion 
and the fluid may be white (milky), but also clear, green, or yellow. The 
discharge can be minimal or copious and a Sudan stain reveals the 
presence of fat globules in the discharge. Table 20 lists various causes of 
galactorrhea, though the most frequent factors are idiopathic (benign 
galactorrhea), suckling, self-manipulation, pharmacologic, pituitary 
prolactinoma, and hypothyroidism (1,2,82). A pregnancy-related rise in 
prolactin levels can lead to a persistent state after a therapeutic abortion, 
delivery without nursing, or miscarriage. Idiopathic or benign 
galactorrhea refers to an end-organ hypersensitivity to normal prolactin 
levels. One cause of hyperprolactinemia is macroprolactinemia with 
elevated amounts of prolactin molecules that are larger than normal 
prolactin molecules, just as immunologically active, but not as 
biologically active; it represents a benign biochemical condition. 
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Table 20. Causes of galactorrhea*
Pregnancy, Lactation 
Stress. Exercise 
Recent Pregnancy Terminated by Spontaneous or Induced Abortion 
Neurogenic 
Chest wall disorders 
foreplay) 
Bronchiectasis and chronic bronchitis 
Herpes zoster  
Chronic crutch use 
Thoracotomy or thoracoptasty 
Burns to chest wall 
Breast (nipple) manipulation or stimulation (sexual 
Chronic inflammatory disease or abscess of breast 
Psychogenic, includiug pseudocyesis and pseudonursiug 
Miscellaneous 
amenorrhea 
Hysterectomy or uterine tumors 
Laparotomy 
Spinal cord disorders and surgery 
Idiopathic normoprolaclinemia, with or without 
Central nervous system abnormalities 
Diffuse brain disease 
Coma 
Pseudotumor cerebri 
Encephalitis and sequelae 
Uremia 
Tumors, infiltrations, structural abnormalities 
Pituitary 
Neurocutaneous syndromes 
Craniopharyngioma 
Pineal tumors 
Other intracranial tumors, cysts, and masses 
Histiocytosis X 
Sarcoidosis 
Stalk section 
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Miscellaneous
Empty sella syndrome 
Pituitary infarction and Sheehan syndrome 
Hyperprolactinemia with or without prolactinoma 
Other functional pituitary tumors 
Hypothyroidism and hyperthyroidism 
Hypogonadism 
Adrenal tumors and hypernephromas 
Nelson syndrome 
Testicular and ovarian tumors 
Polycystic ovary syndrome (PCOS) 
Starvation or refeeding (including anorexia nervosa) 
Cushing disease 
Chronic renal disease 
Cirrhosis 
Acute intermittent porphyria 
Oral Contraceptive pills 
Monoamine oxidase inhibitors 
Amphetamines 
Chlordiazepoxide  
Meprobrunate
Metoclopramide 
Bromocriptine withdrawal 
Cimetidine and ranitidine 
Tamoxifon 
Verapamil 
Isoniazid 
Estrogens 
Opiates (including codeine and heroin) 
Phenothiazines, thioxanthenes, other psychotropic drugs 
Tricyclic antidepressants 
Other chemotherapy drugs (cisplatin, cytosine arabinoside, 
adriamycin) 
Others 
• With permission from: Greydanus DE. Breast and gynecological isorders. In:  
Hofmann AD, Greydanus DE, eds. Adolescent medicine, 3rd ed. Stamford, 
CT: Appleton Lange, 1997:531.  
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A wide variety of pbarmacologic agents can induce 
byperprolactinemia due to underlying mechanisms as listed in table 21. 
Hyperprolactinemia can develop in adolescent males who were treated 
in childhood with chemotherapeutic agents (as doxorubicin, cytosine 
arabinoside, cisplatin) or with testicular radiation. Other pharmacologic 
agents include oral contraceptives (noted with taking or withdrawal), 
methyltestosterone, spironolactone, reserpine, and others. The 
relationship of heavy marijuana use and galactorrhea remains anecdotal 
and controversial. If an offending drug is stopped, galactorrhea usually 
resolves. Hyperprolactinemia may result from hypothyroidism (rarely 
hyperthyroidism), stress, depression, anxiety, hypothalamic injury 
(surgery, rumor, infection), exercise, intercostal nerve stimulation, 
gonadal hypofunction, polycystic ovarian syndrome (PCOS) and other 
conditions noted in table 20. Moderate hyperprolactinemia (less than 
1750 mU/L) can develop in hypothyroidism and polycystic ovarian 
syndrome (PCOS).  
Table 21. Mechanisms of drug-induced galactorrhea 
Dopamine receptor blockers 
Phenothiazines 
Butryophenones 
Tricyclic antidepressanl  
Dopamine depletors         
       Cocaine 
Lactotroph stimulators 
Verapamil 
Narcotics (opiates) 
High-dose estrogens 
Gastrointestinal dopamine antagonist 
              Metoclopramide 
Evaluation of galactorrhea depends on the findings of a careful 
history and physical examination (1,2). A cytologic evaluation of the 
discharge fluid can be performed along with serum gonadotropins, 
prolactin, thyroid screen, and a bead MRI or CT. Management of 
galactorrhea depends on the underlying factor(s). If there is an offending 
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drug, it should be stopped, as should breas1 manipulation if causative. 
Any thyroid dysfunction should be identified and corrected. 
Most pituitary prolactinomas produce prolac1in levels of 80 to 200 
ng/ml or higher. The spectrum of this lesion ranges from a 
microadenoma (3-10 mm mass) to a macroadenoma (10 mm or more in 
diameter) with sella turcica erosion and optic nerve impingement. A 
microadenoma can present with a stable, non-progressive clinical course 
in which serum prolactin (less than 3000 mU/L) is 2 to 10 times normal 
and symptoms include amenorrhea due to anovulation and galactorrhea. 
A macroadenoma may present with galactorrhea along with a variety of 
symptoms (see table 22); the prolactin level is very high at 8,000 mU/L 
or more. Visual field studies (looking for bite1uporal hemianopsia) and a 
head CT/MRI may reveal the presence of a pituitary adenoma. 
Management of a pituitary adenoma depends on its size, but often a 
dopamine agonist is used, as bromocriptine, to remove the tumor if it is 
small enough; a macroadenoma may be reduced in size with a dopamine 
agonist followed by surgery (i.e., transspenoidal resection) [85]. Other 
dopamine agonists include L-dopa and ergotoxine. 
Table 22. Symptoms of pituitary microadenoma 
Menstrual change (Amenorrhea) 
Headaches 
Peripheral vision loss       
Appetite changes 
Abnormal sexual development 
Polyuria, polyphagia, polydipsia 
Infertility 
Loss of libido  
Impotence in males 
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